AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 33822469 — intervention group
Group type: COMPARATOR
Intervention: placebo
Number of subjects: 70
Study 36181473 — intervention group
Group type: EXPERIMENTAL
Intervention: Guilt proneness
Number of subjects: 156
Study 36181473 — intervention group
Group type: EXPERIMENTAL
Intervention: Shame proneness
Number of subjects: 156
Study 36181473 — intervention group
Group type: EXPERIMENTAL
Intervention: Failure priming
Number of subjects: 156
Study 36181473 — intervention group
Group type: EXPERIMENTAL
Intervention: Success priming
Number of subjects: 156
Study 34374425 — intervention group
Group type: EXPERIMENTAL
Intervention: WRSS1 vaccine (3 doses of 3 × 106 CFU)
Number of subjects: 2
Study 34374425 — intervention group
Group type: EXPERIMENTAL
Intervention: WRSS1 vaccine (3 doses of 3 × 105 CFU)
Number of subjects: 2
Study 34374425 — intervention group
Group type: EXPERIMENTAL
Intervention: WRSS1 vaccine
Number of subjects: 2
Study 36451722 — intervention group
Group type: EXPERIMENTAL
Intervention: Dexamethasone (8 mg) added to 10 mg hyperbaric bupivacaine 0.5% with 5 µg sufentanil
Number of subjects: 58
Study 36451722 — intervention group
Group type: COMPARATOR
Intervention: Control group received 10 mg hyperbaric bupivacaine 0.5% with 5 µg sufentanil and 2 ml normal saline
Number of subjects: 58
Study 33849166 — intervention group
Group type: EXPERIMENTAL
Intervention: FEMALE health education
Number of subjects: 428
Study 33849166 — intervention group
Group type: COMPARATOR
Intervention: Control group (no intervention)
Number of subjects: 428
Study 35279142 — intervention group
Group type: EXPERIMENTAL
Intervention: Daily supportive text messages (Text4Support) and mental health peer support
Number of subjects: 10000
Study 35279142 — intervention group
Group type: EXPERIMENTAL
Intervention: Daily supportive text messages (Text4Support)
Number of subjects: 10000
Study 35279142 — intervention group
Group type: EXPERIMENTAL
Intervention: Mental health peer support
Number of subjects: 10000
Study 33942795 — intervention group
Group type: EXPERIMENTAL
Intervention: Fluoxetine
Number of subjects: 0
Study 33942795 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study 32852343 — intervention group
Group type: EXPERIMENTAL
Intervention: Ultrathin-strut biodegradable polymer-coated sirolimus-eluting stent
Number of subjects: 0
Study 32852343 — intervention group
Group type: COMPARATOR
Intervention: Very thin-strut durable polymer-coated everolimus-eluting stent
Number of subjects: 0
Study 32852343 — intervention group
Group type: EXPERIMENTAL
Intervention: Ultrathin-strut DES
Number of subjects: 0
Study 35838507 — intervention group
Group type: EXPERIMENTAL
Intervention: Biofeedback (BF) and Manual Therapy (MT) with Postural Exercises (PE)
Number of subjects: 31
Study 35838507 — intervention group
Group type: COMPARATOR
Intervention: Biofeedback (BF) and Manual Therapy (MT) with Transcutaneous Electrical Nerve Stimulation (TENS)
Number of subjects: 31
Study 32924240 — intervention group
Group type: EXPERIMENTAL
Intervention: Wing-retained FPDs
Number of subjects: 30
Study 32924240 — intervention group
Group type: EXPERIMENTAL
Intervention: Inlay-retained FPDs
Number of subjects: 30
Study 32924240 — intervention group
Group type: EXPERIMENTAL
Intervention: Both designs
Number of subjects: 30
Study 32924240 — intervention group
Group type: EXPERIMENTAL
Intervention: Plaque, gingival, and periodontal scores
Number of subjects: 30
Study 32343882 — intervention group
Group type: EXPERIMENTAL
Intervention: Sarilumab 200 mg
Number of subjects: 1144
Study 32343882 — intervention group
Group type: COMPARATOR
Intervention: Adalimumab 40 mg
Number of subjects: 1144
Study 32343882 — intervention group
Group type: EXPERIMENTAL
Intervention: Sarilumab 150 mg + Methotrexate
Number of subjects: 1144
Study 32343882 — intervention group
Group type: EXPERIMENTAL
Intervention: Sarilumab 200 mg + Methotrexate
Number of subjects: 1144
Study 32343882 — intervention group
Group type: COMPARATOR
Intervention: Placebo + Methotrexate
Number of subjects: 1144
Study 33620076 — intervention group
Group type: EXPERIMENTAL
Intervention: Pulse Arrival Time (PAT)
Number of subjects: 5
Study 33620076 — intervention group
Group type: EXPERIMENTAL
Intervention: PAT index (PAT_I)
Number of subjects: 5
Study 33620076 — intervention group
Group type: EXPERIMENTAL
Intervention: PAT and PAT_I together
Number of subjects: 5
Study 33620076 — intervention group
Group type: COMPARATOR
Intervention: Control group (no hemorrhage)
Number of subjects: 5
Study 34519802 — intervention group
Group type: EXPERIMENTAL
Intervention: Inosine (n = 149)
Number of subjects: 298
Study 34519802 — intervention group
Group type: COMPARATOR
Intervention: Placebo (n = 149)
Number of subjects: 298
Study 34519802 — intervention group
Group type: EXPERIMENTAL
Intervention: Inosine
Number of subjects: 298
Study 34519802 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 298
Study 35841234 — intervention group
Group type: EXPERIMENTAL
Intervention: Soticlestat
Number of subjects: 141
Study 32441386 — intervention group
Group type: EXPERIMENTAL
Intervention: Superficial cryotherapy (8 to 10 seconds freeze-thaw cycles)
Number of subjects: 75
Study 32441386 — intervention group
Group type: EXPERIMENTAL
Intervention: Superficial cryotherapy (13 to 15 seconds freeze-thaw cycles)
Number of subjects: 75
Study 32441386 — intervention group
Group type: EXPERIMENTAL
Intervention: Superficial cryotherapy (3 to 5 seconds freeze-thaw cycles)
Number of subjects: 75
Study 32880803 — intervention group
Group type: EXPERIMENTAL
Intervention: Low-dose rivaroxaban
Number of subjects: 1248214
Study 36257081 — intervention group
Group type: EXPERIMENTAL
Intervention: Time-restricted feeding (16/8) plus a low-sugar diet
Number of subjects: 0
Study 32101488 — intervention group
Group type: EXPERIMENTAL
Intervention: Aloe-vera
Number of subjects: 26
Study 32101488 — intervention group
Group type: COMPARATOR
Intervention: Sodium bicarbonate 5%
Number of subjects: 26
Study 34726808 — intervention group
Group type: EXPERIMENTAL
Intervention: NB-OMP (NB-UVB and dexamethasone oral mini-pulse therapy)
Number of subjects: 80
Study 34726808 — intervention group
Group type: COMPARATOR
Intervention: NB-placebo (NB-UVB and placebo)
Number of subjects: 80
Study 34348954 — intervention group
Group type: EXPERIMENTAL
Intervention: Recovery-focused therapy (RfT) for older adults with BD; specific dosage and duration not mentioned.
Number of subjects: 8
Study 32586587 — intervention group
Group type: EXPERIMENTAL
Intervention: Rivaroxaban 10 mg daily for 45 days
Number of subjects: 9812
Study 32586587 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 9812
Study 34215025 — intervention group
Group type: EXPERIMENTAL
Intervention: Efpeglenatide (4 or 6 mg weekly subcutaneous injections)
Number of subjects: 4076
Study 34215025 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 4076
Study 32346886 — intervention group
Group type: EXPERIMENTAL
Intervention: Proactive rapid genetic counseling and testing
Number of subjects: 320
Study 32346886 — intervention group
Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 320
Study 35120127 — intervention group
Group type: EXPERIMENTAL
Intervention: CC-11050 (PDE4i)
Number of subjects: 200
Study 35120127 — intervention group
Group type: EXPERIMENTAL
Intervention: everolimus (mTORi)
Number of subjects: 200
Study 35120127 — intervention group
Group type: EXPERIMENTAL
Intervention: auranofin (oral gold salt)
Number of subjects: 200
Study 35120127 — intervention group
Group type: EXPERIMENTAL
Intervention: ergocalciferol (vitamin D)
Number of subjects: 200
Study 35120127 — intervention group
Group type: COMPARATOR
Intervention: Control
Number of subjects: 200
Study 33588908 — intervention group
Group type: EXPERIMENTAL
Intervention: Intravenous alteplase administration (IVT) at a dosage of 0.9 mg/kg followed by endovascular treatment (EVT)
Number of subjects: 540
Study 33588908 — intervention group
Group type: COMPARATOR
Intervention: Direct endovascular treatment (EVT)
Number of subjects: 540
Study 33588908 — intervention group
Group type: EXPERIMENTAL
Intervention: Intravenous alteplase administration (IVT) followed by EVT
Number of subjects: 540
Study 32190655 — intervention group
Group type: EXPERIMENTAL
Intervention: Sensory subthreshold TENS
Number of subjects: 0
Study 32190655 — intervention group
Group type: EXPERIMENTAL
Intervention: Sensory suprathreshold TENS
Number of subjects: 0
Study 36384648 — intervention group
Group type: EXPERIMENTAL
Intervention: Telemedicine visit (Arm T)
Number of subjects: 46
Study 36384648 — intervention group
Group type: COMPARATOR
Intervention: In-person visit (Arm I)
Number of subjects: 46
Study 36384648 — intervention group
Group type: EXPERIMENTAL
Intervention: Telemedicine visit (Arm T) after second visit
Number of subjects: 46
Study 36384648 — intervention group
Group type: COMPARATOR
Intervention: In-person visit (Arm I) after second visit
Number of subjects: 46
Study 36217012 — intervention group
Group type: EXPERIMENTAL
Intervention: Osteopathic manipulative treatment (OMT)
Number of subjects: 59
Study 36217012 — intervention group
Group type: EXPERIMENTAL
Intervention: Myofascial release (MRT), muscle energy (MET), and soft tissue techniques (STT)
Number of subjects: 59
Study 32114570 — intervention group
Group type: EXPERIMENTAL
Intervention: Mobile teledermoscopy
Number of subjects: 98
Study 35967467 — intervention group
Group type: EXPERIMENTAL
Intervention: Dry needling under EMG guidance (DN-EMG)
Number of subjects: 30
Study 35967467 — intervention group
Group type: COMPARATOR
Intervention: Dry needling without EMG guidance (DN)
Number of subjects: 30
Study 33146620 — intervention group
Group type: EXPERIMENTAL
Intervention: Pregnant+ app and usual care
Number of subjects: 238
Study 33146620 — intervention group
Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 238
Study 35505463 — intervention group
Group type: EXPERIMENTAL
Intervention: Individual hypnotherapy
Number of subjects: 119
Study 35505463 — intervention group
Group type: COMPARATOR
Intervention: Group hypnotherapy
Number of subjects: 119
Study 35505463 — intervention group
Group type: EXPERIMENTAL
Intervention: Both interventions
Number of subjects: 119
Study 34978317 — intervention group
Group type: EXPERIMENTAL
Intervention: Training monitoring based on intensities around 400 m pace (92 and 97% of 400 m speed)
Number of subjects: 20
Study 34978317 — intervention group
Group type: COMPARATOR
Intervention: Different heart rate zones (EN2 and EN2+)
Number of subjects: 20
Study 35685584 — intervention group
Group type: EXPERIMENTAL
Intervention: Adenovirus pneumonia
Number of subjects: 220
Study 35685584 — intervention group
Group type: COMPARATOR
Intervention: Bacterial pneumonia
Number of subjects: 220
Study 34129389 — intervention group
Group type: EXPERIMENTAL
Intervention: Aerosol therapy (specific medications not detailed)
Number of subjects: 1006
Study 34129389 — intervention group
Group type: EXPERIMENTAL
Intervention: Bronchodilators
Number of subjects: 1006
Study 34129389 — intervention group
Group type: EXPERIMENTAL
Intervention: Mucus-regulating agents
Number of subjects: 1006
Study 34129389 — intervention group
Group type: EXPERIMENTAL
Intervention: Aerosol therapy (general)
Number of subjects: 1006
Study 33402130 — intervention group
Group type: EXPERIMENTAL
Intervention: SOX
Number of subjects: 110
Study 33402130 — intervention group
Group type: COMPARATOR
Intervention: mFOLFOX6
Number of subjects: 110
Study 33350447 — intervention group
Group type: EXPERIMENTAL
Intervention: Rosuvastatin therapy for 48 weeks
Number of subjects: 0
Study 33350447 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study 34171967 — intervention group
Group type: EXPERIMENTAL
Intervention: Group-based psychosocial intervention with weekly sessions for up to four weeks.
Number of subjects: 19
Study 33825525 — intervention group
Group type: EXPERIMENTAL
Intervention: Outcome-based student assessment (OBSA)
Number of subjects: 233
Study 35091853 — intervention group
Group type: EXPERIMENTAL
Intervention: Workplace health promotion (WHP) program including healthy mental health module, anxiety management technique, mindfulness for stress, and stress at work delivered through Occupational Stress Management Course and Employee Assistance Program.
Number of subjects: 88
Study 35091853 — intervention group
Group type: EXPERIMENTAL
Intervention: Workplace health promotion (WHP) program
Number of subjects: 88
Study 35091853 — intervention group
Group type: COMPARATOR
Intervention: Control group (general brochure on stress)
Number of subjects: 88
Study 34216871 — intervention group
Group type: EXPERIMENTAL
Intervention: Varenicline
Number of subjects: 190
Study 34216871 — intervention group
Group type: COMPARATOR
Intervention: Control (placebo)
Number of subjects: 190
Study 35805451 — intervention group
Group type: EXPERIMENTAL
Intervention: Clinical Pilates exercises combined with conventional physical therapy (CPT)
Number of subjects: 40
Study 35805451 — intervention group
Group type: COMPARATOR
Intervention: Conventional physical therapy (CPT)
Number of subjects: 40
Study 32558050 — intervention group
Group type: EXPERIMENTAL
Intervention: Non-pharmacological interventions (including mindfulness and behavioural techniques)
Number of subjects: 0
Study 32558050 — intervention group
Group type: EXPERIMENTAL
Intervention: Interventions combining mindfulness and behavioural techniques
Number of subjects: 0
Study 32558050 — intervention group
Group type: COMPARATOR
Intervention: Non-pharmacological interventions
Number of subjects: 0
Study 35959221 — intervention group
Group type: EXPERIMENTAL
Intervention: Hysteroscopic cold broad sword play + drospirenone and ethinylestradiol tablets
Number of subjects: 108
Study 35959221 — intervention group
Group type: COMPARATOR
Intervention: Hysteroscopic cold broad sword play + estrogen and progestin sequential therapy
Number of subjects: 108
Study 33529095 — intervention group
Group type: EXPERIMENTAL
Intervention: Decompressive craniectomy
Number of subjects: 0
Study 33529095 — intervention group
Group type: COMPARATOR
Intervention: Maximum medical management
Number of subjects: 0
Study 32306606 — intervention group
Group type: EXPERIMENTAL
Intervention: Robot-assisted surgery
Number of subjects: 130
Study 32306606 — intervention group
Group type: COMPARATOR
Intervention: Laparoscopic surgery
Number of subjects: 130
Study 35130956 — intervention group
Group type: EXPERIMENTAL
Intervention: Taped filter mask
Number of subjects: 8
Study 35130956 — intervention group
Group type: EXPERIMENTAL
Intervention: Surgical mask
Number of subjects: 8
Study 33722075 — intervention group
Group type: EXPERIMENTAL
Intervention: ACC walking intervention
Number of subjects: 38
Study 33722075 — intervention group
Group type: COMPARATOR
Intervention: SS walking intervention
Number of subjects: 38
Study 33253970 — intervention group
Group type: EXPERIMENTAL
Intervention: Nutritional supplementation
Number of subjects: 1200000
Study 33253970 — intervention group
Group type: EXPERIMENTAL
Intervention: Nutritional education
Number of subjects: 1200000
Study 33253970 — intervention group
Group type: EXPERIMENTAL
Intervention: Management of malnutrition
Number of subjects: 1200000
Study 33300382 — intervention group
Group type: EXPERIMENTAL
Intervention: Acupuncture intervention
Number of subjects: 106
Study 33300382 — intervention group
Group type: COMPARATOR
Intervention: Wait-list control
Number of subjects: 106
Study 34448354 — intervention group
Group type: EXPERIMENTAL
Intervention: Alveolar ridge preservation (ARP) using deproteinized bovine bone mineral containing 10% collagen (DBBM‐C) covered by a collagen membrane
Number of subjects: 14
Study 34448354 — intervention group
Group type: COMPARATOR
Intervention: Spontaneous healing (control)
Number of subjects: 14
Study 34448354 — intervention group
Group type: EXPERIMENTAL
Intervention: Alveolar ridge preservation (ARP)
Number of subjects: 14
Study 36494823 — intervention group
Group type: EXPERIMENTAL
Intervention: Special orthopaedic geriatrics (SOG) care model
Number of subjects: 310
Study 36494823 — intervention group
Group type: COMPARATOR
Intervention: Usual orthopaedic care without orthogeriatric co-management
Number of subjects: 310
Study 33790039 — intervention group
Group type: EXPERIMENTAL
Intervention: INTRINSIC score (risk prediction score)
Number of subjects: 451
Study 33790039 — intervention group
Group type: EXPERIMENTAL
Intervention: INTRINSIC score <2
Number of subjects: 451
Study 33790039 — intervention group
Group type: EXPERIMENTAL
Intervention: INTRINSIC score <3
Number of subjects: 451
Study 33790039 — intervention group
Group type: EXPERIMENTAL
Intervention: INTRINSIC score
Number of subjects: 451
Study 32421737 — intervention group
Group type: EXPERIMENTAL
Intervention: Helping Mothers Survive Bleeding after Birth training
Number of subjects: 636
Study 35443813 — intervention group
Group type: EXPERIMENTAL
Intervention: Aerobic training (12 weeks)
Number of subjects: 0
Study 35443813 — intervention group
Group type: COMPARATOR
Intervention: Home-based exercise program (Control)
Number of subjects: 0
Study 34252990 — intervention group
Group type: EXPERIMENTAL
Intervention: CLOSE protocol guided fixed 50 W HPSD
Number of subjects: 40
Study 34252990 — intervention group
Group type: COMPARATOR
Intervention: Standard power settings (20 W posterior and 40 W roof and anterior wall)
Number of subjects: 40
Study 34225318 — intervention group
Group type: EXPERIMENTAL
Intervention: Auditory Training (AT)
Number of subjects: 99
Study 34225318 — intervention group
Group type: EXPERIMENTAL
Intervention: Audiovisual Training (AVT)
Number of subjects: 99
Study 34225318 — intervention group
Group type: EXPERIMENTAL
Intervention: Combination of Auditory and Audiovisual Training (AT/AVT)
Number of subjects: 99
Study 34225318 — intervention group
Group type: COMPARATOR
Intervention: Control (untrained talkers)
Number of subjects: 99
Study 34034968 — intervention group
Group type: EXPERIMENTAL
Intervention: Spinal manipulation
Number of subjects: 0
Study 34034968 — intervention group
Group type: EXPERIMENTAL
Intervention: Perineural electrical dry needling
Number of subjects: 0
Study 34034968 — intervention group
Group type: COMPARATOR
Intervention: Control group not specified
Number of subjects: 0
Study 35893409 — intervention group
Group type: EXPERIMENTAL
Intervention: Diaphragm visual biofeedback by RUSI in conjunction with high-intensity IMT (RUSI+IMT)
Number of subjects: 64
Study 35893409 — intervention group
Group type: COMPARATOR
Intervention: Isolated high-intensity IMT (IMT)
Number of subjects: 64
Study 33051044 — intervention group
Group type: EXPERIMENTAL
Intervention: Exercise group (Ex)
Number of subjects: 24
Study 33051044 — intervention group
Group type: EXPERIMENTAL
Intervention: Taurine supplementation + exercise group (TauEx)
Number of subjects: 24
Study 33051044 — intervention group
Group type: COMPARATOR
Intervention: Taurine supplementation group (Tau)
Number of subjects: 24
Study 35986197 — intervention group
Group type: EXPERIMENTAL
Intervention: FDC (aripiprazole/divalproex sodium 5/500 mg)
Number of subjects: 24
Study 35986197 — intervention group
Group type: COMPARATOR
Intervention: Aripiprazole 5mg
Number of subjects: 24
Study 35986197 — intervention group
Group type: COMPARATOR
Intervention: Divalproex sodium 500mg
Number of subjects: 24
Study 32063041 — intervention group
Group type: EXPERIMENTAL
Intervention: Electronic profiling/messaging combined with academic detailing intervention
Number of subjects: 5499
Study 32063041 — intervention group
Group type: COMPARATOR
Intervention: Control group (standard care)
Number of subjects: 5499
Study 36070132 — intervention group
Group type: EXPERIMENTAL
Intervention: TPIP 112.5 µg (n=6)
Number of subjects: 42
Study 36070132 — intervention group
Group type: EXPERIMENTAL
Intervention: TPIP 225 µg QD for 7 days (n=6)
Number of subjects: 42
Study 36070132 — intervention group
Group type: EXPERIMENTAL
Intervention: TPIP 112.5 µg QD for 4 days followed by 225 µg QD for 3 days (n=6)
Number of subjects: 42
Study 36070132 — intervention group
Group type: COMPARATOR
Intervention: Placebo (n=2 for single-dose, n=4 for multiple-dose)
Number of subjects: 42
Study 33428219 — intervention group
Group type: EXPERIMENTAL
Intervention: Telehealth care (TC)
Number of subjects: 0
Study 33428219 — intervention group
Group type: COMPARATOR
Intervention: Standard care (SC)
Number of subjects: 0
Study 32454191 — intervention group
Group type: EXPERIMENTAL
Intervention: Intensity Modulated Radiation Therapy with Deep Inspiration Breath Hold (IMRT-DIBH)
Number of subjects: 40
Study 32454191 — intervention group
Group type: COMPARATOR
Intervention: 3-Dimensional Conformal Radiation Therapy (3DCRT)
Number of subjects: 40
Study 36471430 — intervention group
Group type: EXPERIMENTAL
Intervention: Symptom-driven ICS/LABA management strategy
Number of subjects: 0
Study 36471430 — intervention group
Group type: COMPARATOR
Intervention: Traditional maintenance ICS treatment and symptom-driven SABA
Number of subjects: 0
Study 33300950 — intervention group
Group type: EXPERIMENTAL
Intervention: Capecitabine (650 mg/m2 twice a day for 1 year)
Number of subjects: 443
Study 33300950 — intervention group
Group type: COMPARATOR
Intervention: Observation
Number of subjects: 443
Study 33300950 — intervention group
Group type: EXPERIMENTAL
Intervention: Capecitabine
Number of subjects: 443
Study 33227646 — intervention group
Group type: EXPERIMENTAL
Intervention: 800 mg DHA/day
Number of subjects: 726
Study 33227646 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 726
Study 35759328 — intervention group
Group type: EXPERIMENTAL
Intervention: Evidence-based chatbot intervention (IG)
Number of subjects: 513
Study 35759328 — intervention group
Group type: COMPARATOR
Intervention: Usual care (CG)
Number of subjects: 513
Study 32810293 — intervention group
Group type: EXPERIMENTAL
Intervention: IDF criteria for MetS diagnosis
Number of subjects: 981
Study 32810293 — intervention group
Group type: EXPERIMENTAL
Intervention: Duncan et al, Rodriguez‐Moran et al, Cruz and Goran criteria for MetS diagnosis
Number of subjects: 981
Study 32810293 — intervention group
Group type: COMPARATOR
Intervention: Prevalence of MetS in boys
Number of subjects: 981
Study 32810293 — intervention group
Group type: COMPARATOR
Intervention: Prevalence of MetS in girls
Number of subjects: 981
Study 32810293 — intervention group
Group type: COMPARATOR
Intervention: Concordance values for girls
Number of subjects: 981
Study 35032862 — intervention group
Group type: EXPERIMENTAL
Intervention: Bariatric surgery
Number of subjects: 100
Study 35032862 — intervention group
Group type: COMPARATOR
Intervention: Class III obese
Number of subjects: 100
Study 34158057 — intervention group
Group type: EXPERIMENTAL
Intervention: Insulin treatment
Number of subjects: 2418
Study 34158057 — intervention group
Group type: COMPARATOR
Intervention: No insulin treatment
Number of subjects: 2418
Study 34158057 — intervention group
Group type: EXPERIMENTAL
Intervention: Apabetalone
Number of subjects: 2418
Study 35341380 — intervention group
Group type: EXPERIMENTAL
Intervention: Group music intervention (12 sessions over 4 weeks)
Number of subjects: 19
Study 35538396 — intervention group
Group type: EXPERIMENTAL
Intervention: Point-of-care (PoC) HCV RNA testing and direct-acting antiviral (DAA) treatment
Number of subjects: 1410
Study 35538396 — intervention group
Group type: COMPARATOR
Intervention: Conventional care (referral to local clinics)
Number of subjects: 1410
Study 32349879 — intervention group
Group type: EXPERIMENTAL
Intervention: Ceftazidime/Avibactam (CAZ-AVI) followed by colistin + high-dose meropenem
Number of subjects: 0